Advertisement
PXED vs UTI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXED is a Hold and UTI is a StrongBuy.
Momentum Indicator for PXED turns negative, indicating new downward trend
PXED saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator turned negative. In 21 of the 22 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PXED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for PXED entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PXED's RSI Indicator exited the oversold zone, 2 of 3 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for PXED just turned positive on October 22, 2026. Looking at past instances where PXED's MACD turned positive, the stock continued to rise in 8 of 10 cases over the following month. The odds of a continued upward trend are 80%.
Following a +4.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where PXED advanced for three days, in 31 of 49 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
PXED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.600) is normal, around the industry mean (1.260). P/E Ratio (10.075) is within average values for comparable stocks, (9.322). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.036) settles around the average of (3.423) among similar stocks. P/S Ratio (0.945) is also within normal values, averaging (27.566).
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. PXED’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PXED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
UTI in upward trend: price rose above 50-day moving average on October 22, 2026
UTI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 38 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on UTI as a result. In 79 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The 10-day moving average for UTI crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +1.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTI advanced for three days, in 258 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 188 of 250 cases where UTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The 10-day RSI Indicator for UTI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 28 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 69 cases where UTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
UTI broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. UTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: UTI's P/B Ratio (3.472) is slightly higher than the industry average of (1.260). UTI has a moderately high P/E Ratio (35.000) as compared to the industry average of (9.322). Projected Growth (PEG Ratio) (1.642) is also within normal values, averaging (1.327). Dividend Yield (0.004) settles around the average of (3.423) among similar stocks. P/S Ratio (1.320) is also within normal values, averaging (27.566).
UTI | ||
|---|---|---|
OUTLOOK RATING 1..100 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 69 | |
SMR RATING 1..100 | 68 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 12 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PXED | UTI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 70% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 80% | N/A |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 87% | 2 days ago 78% |
| Advances ODDS (%) | 13 days ago 63% | 9 days ago 78% |
| Declines ODDS (%) | 2 days ago 84% | 2 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PXED’s FA Score shows that 0 FA rating(s) are green while UTI’s FA Score has 1 green FA rating(s).
- PXED’s FA Score: 0 green, 5 red.
- UTI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PXED’s TA Score shows that 5 TA indicator(s) are bullish while UTI’s TA Score has 5 bullish TA indicator(s).
- PXED’s TA Score: 5 bullish, 3 bearish.
- UTI’s TA Score: 5 bullish, 4 bearish.
Price Growth
PXED (@Other Consumer Specialties) experienced а -4.45% price change this week, while UTI (@Other Consumer Specialties) price change was -2.03% for the same time period.
The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -5.77%. For the same industry, the average monthly price growth was -11.69%, and the average quarterly price growth was -23.61%.
Reported Earning Dates
UTI is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Other Consumer Specialties (-5.77% weekly)‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.
Advertisement
PXED and
Correlation & Price change
A.I.dvisor indicates that over the last year, PXED has been loosely correlated with STRA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PXED jumps, then STRA could also see price increases.
| Ticker / NAME | Correlation To PXED | 1D Price Change % | ||
|---|---|---|---|---|
| PXED | 100% | -2.17% | ||
| STRA - PXED | 43% Loosely correlated | +2.03% | ||
| PRDO - PXED | 40% Loosely correlated | N/A | ||
| UTI - PXED | 33% Loosely correlated | -0.78% | ||
| LOPE - PXED | 33% Loosely correlated | -0.61% | ||
| LINC - PXED | 31% Poorly correlated | +1.81% | ||
More | ||||